CADL

Candel Therapeutics (CADL)

About Candel Therapeutics (CADL)

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Details

Daily high

$10.74

Daily low

$10.52

Price at open

$10.69

52 Week High

$11.36

52 Week Low

$4.35

Market cap

775.2M

Dividend yield

0.00%

Volume

798,418

Avg. volume

1.2M

P/E ratio

-10.82

Candel Therapeutics News